| Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial TJ Ford, B Stanley, R Good, P Rocchiccioli, M McEntegart, S Watkins, ... Journal of the American College of Cardiology 72 (23 Part A), 2841-2855, 2018 | 679 | 2018 |
| Outcomes after angiography with sodium bicarbonate and acetylcysteine SD Weisbord, M Gallagher, H Jneid, S Garcia, A Cass, SS Thwin, ... New England Journal of Medicine 378 (7), 603-614, 2018 | 556 | 2018 |
| Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need TJ Ford, D Corcoran, C Berry Heart 104 (4), 284-292, 2018 | 245 | 2018 |
| 1-year outcomes of angina management guided by invasive coronary function testing (CorMicA) TJ Ford, B Stanley, N Sidik, R Good, P Rocchiccioli, M McEntegart, ... Cardiovascular Interventions 13 (1), 33-45, 2020 | 220 | 2020 |
| Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction CJ Rush, C Berry, KG Oldroyd, JP Rocchiccioli, MM Lindsay, RM Touyz, ... JAMA cardiology 6 (10), 1130-1143, 2021 | 192 | 2021 |
| Systemic microvascular dysfunction in microvascular and vasospastic angina TJ Ford, P Rocchiccioli, R Good, M McEntegart, H Eteiba, S Watkins, ... European heart journal 39 (46), 4086-4097, 2018 | 191 | 2018 |
| Ischemia and no obstructive coronary artery disease: prevalence and correlates of coronary vasomotion disorders TJ Ford, E Yii, N Sidik, R Good, P Rocchiccioli, M McEntegart, S Watkins, ... Circulation: Cardiovascular Interventions 12 (12), e008126, 2019 | 166 | 2019 |
| Assessment of vascular dysfunction in patients without obstructive coronary artery disease: why, how, and when TJ Ford, P Ong, U Sechtem, J Beltrame, PG Camici, F Crea, JC Kaski, ... Cardiovascular Interventions 13 (16), 1847-1864, 2020 | 165 | 2020 |
| Effect of low-dose intracoronary alteplase during primary percutaneous coronary intervention on microvascular obstruction in patients with acute myocardial infarction: a … PJ McCartney, H Eteiba, AM Maznyczka, M McEntegart, JP Greenwood, ... Jama 321 (1), 56-68, 2019 | 127 | 2019 |
| Pharmacodynamic effects of a novel prokinetic 5‐HT4 receptor agonist, ATI‐7505, in humans M Camilleri, MI Vazquez‐Roque, D Burton, T Ford, S McKinzie, ... Neurogastroenterology & Motility 19 (1), 30-38, 2007 | 127 | 2007 |
| Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International … H Shimokawa, A Suda, J Takahashi, C Berry, PG Camici, F Crea, ... European heart journal 42 (44), 4592-4600, 2021 | 124 | 2021 |
| Post-stenting fractional flow reserve vs coronary angiography for optimization of percutaneous coronary intervention (TARGET-FFR) D Collison, M Didagelos, M Aetesam-ur-Rahman, S Copt, R McDade, ... European Heart Journal 42 (45), 4656-4668, 2021 | 121 | 2021 |
| Small‐vessel disease in the heart and brain: current knowledge, unmet therapeutic need, and future directions C Berry, N Sidik, AC Pereira, TJ Ford, RM Touyz, JC Kaski, ... Journal of the American Heart Association 8 (3), e011104, 2019 | 116 | 2019 |
| Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction TJ Ford, D Corcoran, S Padmanabhan, A Aman, P Rocchiccioli, R Good, ... European Heart Journal 41 (34), 3239-3252, 2020 | 109 | 2020 |
| Angina: contemporary diagnosis and management TJ Ford, C Berry Heart 106 (5), 387-398, 2020 | 82 | 2020 |
| How to diagnose and manage angina without obstructive coronary artery disease: lessons from the British Heart Foundation CorMicA trial TJ Ford, C Berry Interventional Cardiology Review 14 (2), 76, 2019 | 77 | 2019 |
| Single‐versus 2‐stent strategies for coronary bifurcation lesions: a systematic review and meta‐analysis of randomized trials with long‐term follow‐up TJ Ford, P McCartney, D Corcoran, D Collison, B Hennigan, ... Journal of the American Heart Association 7 (11), e008730, 2018 | 73 | 2018 |
| Physiological predictors of acute coronary syndromes: emerging insights from the plaque to the vulnerable patient TJ Ford, C Berry, B De Bruyne, ASC Yong, P Barlis, WF Fearon, MKC Ng JACC: Cardiovascular Interventions 10 (24), 2539-2547, 2017 | 71 | 2017 |
| Myocardial Perfusion PET for the Detection and Reporting of Coronary Microvascular Dysfunction: A JACC: Cardiovascular Imaging Expert Panel Statement TH Schindler, WF Fearon, M Pelletier-Galarneau, G Ambrosio, U Sechtem, ... Cardiovascular Imaging 16 (4), 536-548, 2023 | 65 | 2023 |
| Rationale and design of the Medical Research Council's precision medicine with Zibotentan in microvascular angina (PRIZE) trial AJ Morrow, TJ Ford, K Mangion, T Kotecha, R Rakhit, G Galasko, S Hoole, ... American Heart Journal 229, 70-80, 2020 | 60 | 2020 |
Alex McConnachieProfessor of Clinical Trial Biostatistics, Robertson Centre for Biostatistics, University of Glasgowglasgow.ac.uk üzerinde doğrulanmış e-posta adresine sahip